2m 2m 2m 2m 2m 2m 2m
ROCKET PHARMACTC (RCKT)
NASDAQ
$2.92+$0.02 (+0.87%)
Price as of Jun 03, 2026 6:32 PM EDT- $335.2MMarket Cap
- -2.36%1-Year Change
- BiotechnologyIndustry
ROCKET PHARMACTC (RCKT)
$2.92+$0.02 (+0.87%)
RCKT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.89 | ||
Change | -$0.13 (-4.30%) | ||
Open | $3.01 | ||
High | $3.01 | ||
Low | $2.86 | ||
Previous Close | $3.02 | ||
Volume | 3,576,532 | ||
30-Day Average Volume | 2,333,589 | ||
1-Week Change | -3.67% | ||
1-Month Change | -18.82% | ||
1-Year Change | -2.36% | ||
3-Year Change | -86.77% | ||
5-Year Change | -93.06% | ||
Fundamentals | |||
Shares Outstanding | 109.2M | ||
Total Assets | $285.4M | ||
Market Cap | $335.2M | ||
Enterprise Value | $286.4M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$47.6M | ||
Free Cash Flow | -$45.5M | ||
EBIT | -$47.1M | ||
EBITDA | -$45.5M | ||
Net Working Capital | $125.4M | ||
EPS | -$0.42 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | 1 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue